Who are the top longevity investors & vc firms in france?

Top longevity investors & vc firms in france include Sofinnova Partners, ARCHIMED Japan, AdBio partners, Auriga Partners, Future Positive Capital, astorya.vc, EQT Life Sciences, HealthCap — 15 firms in total meet the criteria.

What is the typical first check among longevity investors & vc firms in france?

The median first check among the 15 longevity investors & vc firms in france tracked here is $540K.

How many longevity investors & vc firms in france lead rounds?

4 of the 15 longevity investors & vc firms in france tracked here lead investment rounds.

Longevity Investors & VC Firms in France

15 firms in this list, with a median first check of $540K. 4 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Sofinnova Partners 79 people · Leads rounds	Paris	FR	Seed–Late Stage	$540K – $27M	+ Add to CRM
ARCHIMED Japan 22 people · Leads rounds	Lyon	FR	Growth–Late Stage	$10.8M – $1.1B	+ Add to CRM
AdBio partners 21 people	Paris	FR	Seed–Series A	—	+ Add to CRM
Auriga Partners 16 people	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
Future Positive Capital 6 people · Follows rounds	—	FR	Pre-Seed–Series A	—	+ Add to CRM
astorya.vc 7 people	Paris	FR	Pre-Seed–Seed	$110K – $275K	+ Add to CRM
EQT Life Sciences 59 people · Leads rounds	Amsterdam	NL	Seed–Late Stage	$11M – $66M	+ Add to CRM
HealthCap 33 people	Stockholm	SE	Seed–Growth	—	+ Add to CRM
Catalio Capital Management, LP 37 people · Follows rounds	New York	US	Seed–Late Stage	—	+ Add to CRM
NLC 43 people	Amsterdam	NL	Pre-Seed–Seed	—	+ Add to CRM
Unruly Capital 3 people	London	GB	Pre-Seed–Seed	—	+ Add to CRM
Brookstreet Equity Partners 22 people · Leads rounds	London	GB	Series A–Late Stage	—	+ Add to CRM
Aescap Life Sciences 14 people	Amsterdam	NL	Series A–Growth	—	+ Add to CRM
Delta Finance 9 people	Geneva	CH	—	—	+ Add to CRM
Crista Galli Ventures 2 people	London	GB	Pre-Seed–Series A	—	+ Add to CRM

Sofinnova Partners

ParisSeed–Late Stage$540K – $27M

79 people

ARCHIMED Japan

LyonGrowth–Late Stage$10.8M – $1.1B

ParisSeed–Growth$540K – $5.4M

16 people

Future Positive Capital

Pre-Seed–Series A

6 people

astorya.vc

ParisPre-Seed–Seed$110K – $275K

7 people

EQT Life Sciences

AmsterdamSeed–Late Stage$11M – $66M

Catalio Capital Management, LP

New YorkSeed–Late Stage

37 people

NLC

AmsterdamPre-Seed–Seed

Brookstreet Equity Partners

LondonSeries A–Late Stage

22 people

Aescap Life Sciences

AmsterdamSeries A–Growth

Crista Galli Ventures

LondonPre-Seed–Series A

2 people

Frequently asked questions

Who are the top longevity investors & vc firms in france?: Top longevity investors & vc firms in france include Sofinnova Partners, ARCHIMED Japan, AdBio partners, Auriga Partners, Future Positive Capital, astorya.vc, EQT Life Sciences, HealthCap — 15 firms in total meet the criteria.
What is the typical first check among longevity investors & vc firms in france?: The median first check among the 15 longevity investors & vc firms in france tracked here is $540K.
How many longevity investors & vc firms in france lead rounds?: 4 of the 15 longevity investors & vc firms in france tracked here lead investment rounds.

Data sourced from public filings and firms' own websites — see our methodology.

Longevity Investors & VC Firms in France

Frequently asked questions

Related lists